• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有红木籽油的纳米结构脂质载体:皮肤利什曼病的一种潜在新疗法。

Annatto Oil Loaded Nanostructured Lipid Carriers: A Potential New Treatment for Cutaneous Leishmaniasis.

作者信息

Ferreira Marianna Araújo, de Almeida Júnior Renato Ferreira, Onofre Thiago Souza, Casadei Bruna Renata, Farias Kleber Juvenal Silva, Severino Patricia, de Oliveira Franco Camilo Flamarion, Raffin Fernanda Nervo, de Lima E Moura Túlio Flávio Accioly, de Melo Barbosa Raquel

机构信息

Laboratory of Drug Development, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.

Department of Clinical and Toxicological Analysis, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil.

出版信息

Pharmaceutics. 2021 Nov 11;13(11):1912. doi: 10.3390/pharmaceutics13111912.

DOI:10.3390/pharmaceutics13111912
PMID:34834327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8618414/
Abstract

Annatto ( L.) is extensively used as food pigment worldwide. Recently, several studies have found it to have healing and antioxidant properties, as well as effective action against leishmaniasis. Therefore, the purpose of this study was to incorporate the oil obtained from annatto seeds into a nanostructured lipid carrier (NLC) and evaluate its physicochemical properties and biological activity against . Nanoparticles were prepared by the fusion-emulsification and ultrasonication method, with the components Synperonic™ PE (PL) as the surfactant, cetyl palmitate (CP) or myristyl myristate (MM) as solid lipids, annatto oil (AO) (2% and 4%, /) as liquid lipid and active ingredient, and ultra-pure water. Physicochemical and biological characterizations were carried out to describe the NLCs, including particle size, polydispersity index (PDI), and zeta potential (ZP) by dynamic light scattering (DLS), encapsulation efficiency (EE%), thermal behavior, X-ray diffraction (XRD), transmission electron microscopy (TEM), Electron Paramagnetic Resonance (EPR), cytotoxicity on BALB/c 3T3 fibroblasts and immortalized human keratinocyte cells, and anti-leishmaniasis activity in vitro. Nanoparticles presented an average diameter of ~200 nm (confirmed by TEM results), a PDI of less than 0.30, ZP between -12.6 and -31.2 mV, and more than 50% of AO encapsulated in NLCs. Thermal analyses demonstrated that the systems were stable at high temperatures with a decrease in crystalline structure due to the presence of AOs (confirmed by XRD). In vitro, the anti-leishmania test displayed good activity in encapsulating AO against . The results indicate that the oily fraction of L. in NLC systems should be evaluated as a potential therapeutic agent against leishmaniasis.

摘要

胭脂树(Bixa orellana L.)在全球范围内被广泛用作食品色素。最近,多项研究发现它具有愈合和抗氧化特性,以及对利什曼病的有效作用。因此,本研究的目的是将从胭脂树种子中提取的油纳入纳米结构脂质载体(NLC),并评估其物理化学性质和对……的生物活性。纳米颗粒通过融合乳化和超声处理方法制备,其成分包括作为表面活性剂的Synperonic™ PE(PL)、作为固体脂质的十六烷基棕榈酸酯(CP)或肉豆蔻酸肉豆蔻酯(MM)、作为液体脂质和活性成分的胭脂树油(AO)(2%和4%,w/v)以及超纯水。对NLC进行了物理化学和生物学表征,包括通过动态光散射(DLS)测定粒径、多分散指数(PDI)和zeta电位(ZP),通过包封率(EE%)、热行为、X射线衍射(XRD)、透射电子显微镜(TEM)、电子顺磁共振(EPR)评估,对BALB/c 3T3成纤维细胞和永生化人角质形成细胞进行细胞毒性测试,以及体外抗利什曼病活性测试。纳米颗粒的平均直径约为200 nm(经TEM结果证实),PDI小于0.30,ZP在-12.6至-31.2 mV之间,且超过50%的AO被包封在NLC中。热分析表明,由于AO的存在,该系统在高温下稳定,晶体结构减少(经XRD证实)。在体外,抗利什曼原虫测试显示包封AO对……具有良好活性。结果表明,NLC系统中的胭脂树油性部分应作为抗利什曼病的潜在治疗剂进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/3374eb2c6637/pharmaceutics-13-01912-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/370277c1c46e/pharmaceutics-13-01912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/5a28e209ba01/pharmaceutics-13-01912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/1c08f29591d8/pharmaceutics-13-01912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/710fe40085e4/pharmaceutics-13-01912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/ad533527b274/pharmaceutics-13-01912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/eeef5461b38a/pharmaceutics-13-01912-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/40a338a00d8e/pharmaceutics-13-01912-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/1e2c88fbe2c0/pharmaceutics-13-01912-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/e677475bbc68/pharmaceutics-13-01912-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/3374eb2c6637/pharmaceutics-13-01912-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/370277c1c46e/pharmaceutics-13-01912-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/5a28e209ba01/pharmaceutics-13-01912-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/1c08f29591d8/pharmaceutics-13-01912-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/710fe40085e4/pharmaceutics-13-01912-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/ad533527b274/pharmaceutics-13-01912-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/eeef5461b38a/pharmaceutics-13-01912-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/40a338a00d8e/pharmaceutics-13-01912-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/1e2c88fbe2c0/pharmaceutics-13-01912-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/e677475bbc68/pharmaceutics-13-01912-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a720/8618414/3374eb2c6637/pharmaceutics-13-01912-g010.jpg

相似文献

1
Annatto Oil Loaded Nanostructured Lipid Carriers: A Potential New Treatment for Cutaneous Leishmaniasis.载有红木籽油的纳米结构脂质载体:皮肤利什曼病的一种潜在新疗法。
Pharmaceutics. 2021 Nov 11;13(11):1912. doi: 10.3390/pharmaceutics13111912.
2
Hybrid Lipid/Clay Carrier Systems Containing Annatto Oil for Topical Formulations.含胭脂树籽油的用于局部制剂的混合脂质/粘土载体系统。
Pharmaceutics. 2022 May 17;14(5):1067. doi: 10.3390/pharmaceutics14051067.
3
Effect of Lipid and Oil Compositions on Physicochemical Properties and Photoprotection of Octyl Methoxycinnamate-loaded Nanostructured Lipid Carriers (NLC).载辛基甲氧基肉桂酸酯的纳米结构化脂质载体(NLC)的脂质和油成分对其理化性质和光保护的影响。
J Oleo Sci. 2020;69(12):1627-1639. doi: 10.5650/jos.ess20093.
4
Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.多潘立酮固体脂质纳米粒和纳米结构脂质载体的制备及体外评价。
Daru. 2011;19(1):23-32.
5
Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.载药纳米结构脂质载体(NLC)的设计与表征及其含西番莲籽油的水凝胶。
Int J Pharm. 2021 May 1;600:120444. doi: 10.1016/j.ijpharm.2021.120444. Epub 2021 Mar 10.
6
Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.甜椒籽油负载的纳米结构化脂质载体(NLC):脂质筛选、析因设计、释放特性和细胞毒性。
Molecules. 2020 Feb 6;25(3):685. doi: 10.3390/molecules25030685.
7
Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis.米替福新负载纳米结构脂质载体的研制及其在治疗皮肤利什曼病中的体内外评价。
Int J Pharm. 2021 Jan 25;593:120109. doi: 10.1016/j.ijpharm.2020.120109. Epub 2020 Nov 28.
8
Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.系统实施质量源于设计(QbD)以开发用于眼部应用的载 NSAID 的纳米结构化脂质载体:制剂前筛选研究和统计混合设计优化变量。
Drug Dev Ind Pharm. 2020 Mar;46(3):443-455. doi: 10.1080/03639045.2020.1724135. Epub 2020 Feb 9.
9
Electron Paramagnetic Resonance and Small-Angle X-ray Scattering Characterization of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Dibucaine Encapsulation.电子顺磁共振和小角 X 射线散射对固体脂质纳米粒和载双卡因纳米结构脂质载体的表征。
Langmuir. 2018 Nov 6;34(44):13296-13304. doi: 10.1021/acs.langmuir.8b02559. Epub 2018 Oct 24.
10
Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of Infection.新型两性霉素 B 载纳米脂质载体治疗感染的体外与体内疗效评价。
Int J Nanomedicine. 2020 Nov 5;15:8659-8672. doi: 10.2147/IJN.S262642. eCollection 2020.

引用本文的文献

1
Lipid-Based Nanocarriers for Topical Therapy of Cutaneous Leishmaniasis: An Insight into the Mechanism of Action.用于皮肤利什曼病局部治疗的脂质纳米载体:作用机制洞察
ACS Omega. 2025 Jun 5;10(23):23873-23888. doi: 10.1021/acsomega.5c00046. eCollection 2025 Jun 17.
2
Nanostructured Lipid Carrier for Intracellular Delivery of a Bis(pyridine-2-carboxamidine) DNA Minor Groove Binder Active against .用于细胞内递送对……具有活性的双(吡啶-2-甲脒)DNA小沟结合剂的纳米结构脂质载体
ACS Omega. 2025 Feb 19;10(8):7795-7805. doi: 10.1021/acsomega.4c08138. eCollection 2025 Mar 4.
3
Annatto ()-Based Nanostructures for Biomedical Applications-A Systematic Review.

本文引用的文献

1
Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis.组蛋白去乙酰化酶抑制剂作为治疗新热带皮肤利什曼病主要病原体巴西利什曼原虫的新型潜在药物。
Biochem Pharmacol. 2020 Oct;180:114191. doi: 10.1016/j.bcp.2020.114191. Epub 2020 Aug 7.
2
Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats.纳米结构脂质载体对放射治疗大鼠体内酮咯酸透皮传递的影响。
Drug Deliv. 2020 Dec;27(1):1218-1230. doi: 10.1080/10717544.2020.1803448.
3
Solid lipid nanoparticles as a novel formulation approach for tanespimycin (17-AAG) against leishmania infections: Preparation, characterization and macrophage uptake.
基于胭脂树橙()的生物医学应用纳米结构——系统评价。 (注:原文括号处内容缺失)
Pharmaceutics. 2024 Sep 29;16(10):1275. doi: 10.3390/pharmaceutics16101275.
4
From Extraction to Stabilization: Employing a 2 Experimental Design in Developing Nutraceutical-Grade Bixin from L.从提取到稳定化:采用双实验设计从胭脂树中开发营养级别的胭脂树素
Foods. 2024 May 23;13(11):1622. doi: 10.3390/foods13111622.
5
Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review.用于治疗利什曼病的载姜黄素纳米结构系统:综述
Beilstein J Nanotechnol. 2024 Jan 4;15:37-50. doi: 10.3762/bjnano.15.4. eCollection 2024.
6
Current Applications of Plant-Based Drug Delivery Nano Systems for Leishmaniasis Treatment.基于植物的药物递送纳米系统在利什曼病治疗中的当前应用
Pharmaceutics. 2022 Oct 29;14(11):2339. doi: 10.3390/pharmaceutics14112339.
7
Hybrid Lipid/Clay Carrier Systems Containing Annatto Oil for Topical Formulations.含胭脂树籽油的用于局部制剂的混合脂质/粘土载体系统。
Pharmaceutics. 2022 May 17;14(5):1067. doi: 10.3390/pharmaceutics14051067.
固体脂质纳米粒作为新型替吡嘧啶(17-AAG)制剂用于利什曼原虫感染的研究:制备、表征和巨噬细胞摄取。
Acta Trop. 2020 Nov;211:105595. doi: 10.1016/j.actatropica.2020.105595. Epub 2020 Jun 23.
4
Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment.负载香芹酚的纳米结构脂质载体作为一种有前途的治疗利什曼病的注射制剂。
Eur J Pharm Sci. 2020 Jul 1;150:105335. doi: 10.1016/j.ejps.2020.105335. Epub 2020 Apr 6.
5
Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.甜椒籽油负载的纳米结构化脂质载体(NLC):脂质筛选、析因设计、释放特性和细胞毒性。
Molecules. 2020 Feb 6;25(3):685. doi: 10.3390/molecules25030685.
6
Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges.纳米材料在利什曼病中的应用:聚焦最新进展与挑战
Nanomaterials (Basel). 2019 Dec 9;9(12):1749. doi: 10.3390/nano9121749.
7
Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8.脂质核纳米胶囊包封提高了强效抗利什曼原虫化合物 CH8 的局部治疗效果。
Nanomedicine. 2020 Feb;24:102121. doi: 10.1016/j.nano.2019.102121. Epub 2019 Oct 28.
8
Praziquantel-Solid Lipid Nanoparticles Produced by Supercritical Carbon Dioxide Extraction: Physicochemical Characterization, Release Profile, and Cytotoxicity.利用超临界二氧化碳萃取法制备吡喹酮固体脂质纳米粒:理化性质表征、释放特性和细胞毒性。
Molecules. 2019 Oct 28;24(21):3881. doi: 10.3390/molecules24213881.
9
Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series.用病灶内注射葡甲胺锑酸盐成功治疗皮肤利什曼病:病例系列
Rev Soc Bras Med Trop. 2019 May 16;52:e20180211. doi: 10.1590/0037-8682-0211-2018.
10
Leishmaniasis among neighbouring endemic countries in the Eastern Mediterranean, African and European regions.东地中海、非洲和欧洲区域相邻流行国家的利什曼病。
East Mediterr Health J. 2019 Mar 19;25(1):66-68. doi: 10.26719/2019.25.1.66.